MOESM3 of Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth

Additional file 3: Fig. S3. Antitumor activity of IFNγ and TCP-1/IFNγ at different dose in the orthotopic CRC model. (A) Picture of the tumors after 7 day treatment (n ≥ 2 per group). (B) Relative tumor mass at the end of experiment. TCP-1/IFNγ at 5 μg/mouse significantly decreased tumor volume. *P < 0.05.